Clinical Trial Update: VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating VRD as induction followed by VR maintenance in newly diagnosed high-risk multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• VRD

Snippet

Sponsor: Sun Yat-sen University | Conditions: Myeloma, Newly Diagnosed | Phase 2 | Status: UNKNOWN